Lista de obras -

A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study

artículo científico publicado en 2014

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

artículo científico publicado en 2010

A three-year, multi-parametric MRI study in patients at presentation with CIS

artículo científico publicado en 2008

Alemtuzumab in early multiple sclerosis

artículo científico publicado en 2009

An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis

artículo científico publicado en 2004

Brain atrophy and lesion load predict long term disability in multiple sclerosis

artículo científico publicado en 2013

Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter

artículo científico publicado en 2012

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

artículo científico publicado en 2010

Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography

artículo científico publicado en 2012

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

artículo científico publicado en 2005

Defining the clinical course of multiple sclerosis: the 2013 revisions

artículo científico publicado en 2014

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

artículo científico publicado en 2005

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

artículo científico publicado en 2011

Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes

scholarly article by Raquel Mitjana et al published 27 February 2014 in Multiple Sclerosis Journal

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects ⬇️

artículo científico publicado el 1 de mayo de 2012

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study

artículo científico publicado en 2011

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

artículo científico publicado en 2007

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes

artículo científico publicado en 2013

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

artículo científico publicado en 2015

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

artículo científico publicado en 2015

Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data

artículo científico publicado en 2011

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

scientific journal article

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

artículo científico publicado en 2010

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

artículo científico publicado en 2011

Glutamate inhibition in MS: the neuroprotective properties of riluzole

artículo científico publicado en 2005

Health-related quality of life in multiple sclerosis: effects of natalizumab

artículo científico publicado en 2007

Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients

artículo científico publicado en 2009

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX

scientific article published on 01 October 2007

Interferons in relapsing remitting multiple sclerosis: a systematic review

artículo científico publicado en 2003

Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial

artículo científico publicado en 2012

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

artículo científico publicado en 2005

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

scientific article published on 21 January 2008

Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR.

artículo científico publicado en 2011

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

artículo científico publicado en 2009

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

artículo científico publicado en 2015

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

artículo científico publicado en 2014

Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years

artículo científico publicado en 2008

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

artículo científico publicado en 2006

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

artículo científico publicado en 2009

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study

artículo científico publicado en 2006

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

artículo científico publicado en 2007

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

artículo científico

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

artículo científico publicado en 2009

Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data

artículo científico publicado en 2011

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

artículo científico publicado en 2014

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

artículo científico publicado en 2007

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

artículo científico publicado en 2007

Oral fingolimod (FTY720) for relapsing multiple sclerosis

artículo científico publicado en 2006

Oral treatment for multiple sclerosis

artículo científico publicado en 2011

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

scientific article published on 13 March 2009

Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

artículo científico publicado en 2008

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

scientific article published on 01 June 2008

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

artículo científico publicado en 2013

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

artículo científico publicado en 2010

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

artículo científico publicado en 2001

Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis

article

Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study

artículo científico publicado en 2010

Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients

artículo científico publicado en 2013

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

artículo científico publicado en 2012

Spinal-cord MRI in multiple sclerosis

artículo científico publicado en 2003

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

artículo científico publicado en 2010

The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis

article

The size of the treatment effect: do patients and proxies agree?

artículo científico publicado en 2009

Vitamin D as an early predictor of multiple sclerosis activity and progression

artículo científico publicado en 2014

Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.

artículo científico publicado en 2006

Lista de obras de

A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

A three-year, multi-parametric MRI study in patients at presentation with CIS

Alemtuzumab in early multiple sclerosis

An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis

Brain atrophy and lesion load predict long term disability in multiple sclerosis

Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Defining the clinical course of multiple sclerosis: the 2013 revisions

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects ⬇️

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

Glutamate inhibition in MS: the neuroprotective properties of riluzole

Health-related quality of life in multiple sclerosis: effects of natalizumab

Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX

Interferons in relapsing remitting multiple sclerosis: a systematic review

Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR.

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

Oral fingolimod (FTY720) for relapsing multiple sclerosis

Oral treatment for multiple sclerosis

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis

Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study

Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

Spinal-cord MRI in multiple sclerosis

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis

The size of the treatment effect: do patients and proxies agree?

Vitamin D as an early predictor of multiple sclerosis activity and progression

Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.